These findings reveal a phosphorylation-palmitoylation axis linking JNK-mediated ASCT2 palmitoylation and glutamine metabolism, offering a potential therapeutic strategy for non-small cell lung cancer. The gene discussed is SLC1A5; the disease is non-small cell lung carcinoma.